日韩av大片在线观看欧美成人不卡|午夜先锋看片|中国女人18毛片水多|免费xx高潮喷水|国产大片美女av|丰满老熟妇好大bbbbbbbbbbb|人妻上司四区|japanese人妻少妇乱中文|少妇做爰喷水高潮受不了|美女人妻被颜射的视频,亚洲国产精品久久艾草一,俄罗斯6一一11萝裸体自慰,午夜三级理论在线观看无码

Dendritic Cell Lectin （DLEC）, also known as BDCA-2, CD303, HECL, and alternatively designated as CLEC4C/CLECSF11/CLECSF7, is a 38 kDa type II transmembrane protein belonging to the C-type lectin family. DLEC is selectively expressed in plasmacytoid dendritic cells （pDCs） and its expression is downregulated as these cells mature.
pDCs are integral to the innate immune response, particularly in the production of IFN-alpha/beta upon exposure to Toll-like receptor （TLR） 7 and TLR9 agonists, such as microbial CpG DNA. The ligation of DLEC on pDCs with specific antibodies has been shown to attenuate the CpG-stimulated production of interferons and to modulate the Th1 response. Monoclonal antibodies targeting CLEC4C have demonstrated efficacy in achieving disease control in patients with cutaneous lupus erythematosus.
The suppression of IFN-alpha production mediated by CLEC4C is regulated through the masking and unmasking of galactose moieties on the protein. This mechanism represents a novel potential strategy for modulating immune responses in various pathological conditions.